We also showed that probes ICAM1, calreticulin, PD-L1, neuropilin-1, galectin-3 and MPO were spatially associated with immunogenic cell death and, together with the enriched standard cell types, they might serve as an early predictive biomarker of induced anti-tumor immunity in situ. This evidence concerns the gene LGALS3 and neoplasm.